- Home
- WTBA vs BDTX Comparison
WTBA vs BDTX Comparison
Compare WTBA & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | BDTX |
|---|---|---|
| Founded | 1893 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.6M | 171.9M |
| IPO Year | 2002 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WTBA | BDTX |
|---|---|---|
| Price | $28.86 | $2.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $24.00 | $9.67 |
| AVG Volume (30 Days) | 55.2K | ★ 506.7K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | 35.21 | ★ 130.71 |
| EPS | ★ 1.26 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.80 | N/A |
| Revenue Next Year | $9.39 | N/A |
| P/E Ratio | $22.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.03 | $1.60 |
| 52 Week High | $30.33 | $4.94 |
Technical Indicators
Market Signals| Indicator | WTBA | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.28 | 52.12 |
| Support Level | $27.54 | $1.98 |
| Resistance Level | $30.33 | $2.28 |
| Average True Range (ATR) | 0.57 | 0.10 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 72.93 | 26.67 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.